Logo image of OVXA.I

OVOCA BIO PLC (OVXA.I) Stock Price, Quote, News and Overview

DUB:OVXA - Euronext Dublin - IE00B4XVDC01 - Common Stock - Currency: EUR

0.0195  0 (0%)

OVXA.I Quote, Performance and Key Statistics

OVOCA BIO PLC

DUB:OVXA (4/25/2025, 7:00:00 PM)

0.0195

0 (0%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High0.16
52 Week Low0.01
Market Cap1.72M
Shares88.46M
Float48.95M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO04-21 1987-04-21


OVXA.I short term performance overview.The bars show the price performance of OVXA.I in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 100 200

OVXA.I long term performance overview.The bars show the price performance of OVXA.I in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of OVXA.I is 0.0195 EUR. In the past month the price decreased by -33.9%. In the past year, price decreased by -83.88%.

OVOCA BIO PLC / OVXA Daily stock chart

OVXA.I Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY.DE ELI LILLY & CO 67.07 728.06B
1LLY.MI ELI LILLY & CO 65.28 708.62B
ZEG.DE ASTRAZENECA PLC 16.86 377.93B
JNJ.DE JOHNSON & JOHNSON 15.42 328.85B
NOV.DE NOVO NORDISK A/S-B 18.18 244.48B
1SAN.MI SANOFI 12.19 229.14B
SAN.PA SANOFI 13.83 227.92B
SNW.DE SANOFI 13.77 226.94B
6MK.DE MERCK & CO. INC. 10.7 184.70B
1MRKX.MI MERCK & CO. INC. 9.96 171.87B
PFE.DE PFIZER INC 7.43 115.50B
1PFE.MI PFIZER INC 7.14 111.02B

About OVXA.I

Company Profile

OVXA logo image Ovoca Bio Plc is a clinical-stage biopharmaceutical company, which engages in the women's health, clinical development and commercial planning of BP-101, and novel treatment for women with hypoactive sexual desire disorder (HSDD). The firm is developing Orenetide, a novel medicinal treatment for premenopausal women with hypoactive sexual desire disorder (HSDD). The company is focused on women’s health and identifying novel candidates in areas of high unmet medical need. The Company’s lead product, Orenetide (BP-101), is a novel synthetic peptide for the treatment of HSDD and is conveniently administered through a nasal spray. The spray delivers the drug to olfactory and trigeminal nerves in the nasal cavity where the drug accumulates in the olfactory bulb and further in the brain. The company is also developing a new treatment for women affected by low libido or sex drive. The company owns a patent portfolio that provides effective protection of its technology. The firm operates in Ireland, the United Kingdom and Russia.

Company Info

OVOCA BIO PLC

17 Pembroke Street, Upper

DUBLIN DUBLIN IE

Employees: 5

Company Website: https://ovocabio.com/

Investor Relations: http://www.ovocabio.com/results-reports-presentations/

Phone: 35316619819

OVOCA BIO PLC / OVXA.I FAQ

What is the stock price of OVOCA BIO PLC today?

The current stock price of OVXA.I is 0.0195 EUR.


What is the ticker symbol for OVOCA BIO PLC stock?

The exchange symbol of OVOCA BIO PLC is OVXA and it is listed on the Euronext Dublin exchange.


On which exchange is OVXA.I stock listed?

OVXA.I stock is listed on the Euronext Dublin exchange.


What is OVOCA BIO PLC worth?

OVOCA BIO PLC (OVXA.I) has a market capitalization of 1.72M EUR. This makes OVXA.I a Nano Cap stock.


How many employees does OVOCA BIO PLC have?

OVOCA BIO PLC (OVXA.I) currently has 5 employees.


What are the support and resistance levels for OVOCA BIO PLC (OVXA.I) stock?

OVOCA BIO PLC (OVXA.I) has a support level at 0.01. Check the full technical report for a detailed analysis of OVXA.I support and resistance levels.


Should I buy OVOCA BIO PLC (OVXA.I) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does OVOCA BIO PLC (OVXA.I) stock pay dividends?

OVXA.I does not pay a dividend.


What is the Price/Earnings (PE) ratio of OVOCA BIO PLC (OVXA.I)?

OVOCA BIO PLC (OVXA.I) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.06).


OVXA.I Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to OVXA.I. When comparing the yearly performance of all stocks, OVXA.I is one of the better performing stocks in the market, outperforming 98.33% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

OVXA.I Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to OVXA.I. No worries on liquidiy or solvency for OVXA.I as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OVXA.I Financial Highlights

Over the last trailing twelve months OVXA.I reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 9.01% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -151.63%
ROE -210%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%53.95%
Sales Q2Q%N/A
EPS 1Y (TTM)9.01%
Revenue 1Y (TTM)N/A

OVXA.I Ownership and Analysts


Ownership
Inst OwnersN/A
Ins Owners44.67%
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A